675148-38-6

Basic information

• Product Name: Benzoic acid, 4-[4-(chloromethyl)-5-methyl-2-oxazolyl]-, methyl ester
• CAS NO: 675148-38-6
• Molecular Formula: C13H12ClNO3
• Molecular Weight: 265.696
• Mol File: 675148-38-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-[4-(chloromethyl)-5-methyl-2-oxazolyl]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-[4-(chloromethyl)-5-methyl-2-oxazolyl]-, methyl ester(675148-38-6)
• EPA Substance Registry System: Benzoic acid, 4-[4-(chloromethyl)-5-methyl-2-oxazolyl]-, methyl ester(675148-38-6)

Safety Data

• Hazardous Substances Data: 675148-38-6(Hazardous Substances Data)

Upstream product

• 1571-08-0 methyl 4-formylbenzoate 
• 52178-50-4 Methyl 3-formylbenzoate 

Downstream Products

• 1280693-17-5 4-(5-methyl-4-{[(4-methylphenyl)sulfonyl]methyl}-1,3-oxazol-2-yl)benzoic acid 

Relevant articles and documents

SUBSTITUTED BENZAMIDES AND THEIR USES

Provided herein are Substituted Benzamides, compositions, and method of their manufacture and use.

SUBSTITUTED ARYLOXAZOLES AND THEIR USE

The present application relates to novel substituted aryloxazole derivatives, a method for the production thereof, the use thereof for the treatment and/or prophylaxis of diseases and the use thereof for the production of drugs for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of cardiovascular and metabolic disorders.

Indolyl derivatives as liver-X-receptor (LXR) modulators

The invention relates to compounds of formula (I): and pharmaceutically acceptable salts and pharmaceutically acceptable esters thereof, wherein R1, R2, R3, R4, R5, R6, A, m, n and p are defined as in claim 1. These compounds can be used as pharmaceutical compositions for the treatment of, for example, diabetes.